University of California, Los Angeles

FDA approves 'game changing' drug for melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated.

Sep 04, 2014
popularity 4.8 / 5 (32) | comments 0

Low risk prostate cancer not always low risk

More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ...

May 19, 2014
popularity 5 / 5 (2) | comments 0